Automated Algorithm Based Analysis of Phonocardiograms of Newborns

Sponsor
CSD Labs GmbH (Other)
Overall Status
Completed
CT.gov ID
NCT02105480
Collaborator
(none)
220
1
38.6
5.7

Study Details

Study Description

Brief Summary

The purpose of this double-blind pivotal clinical utility study is to determine on a large patient population whether heart murmurs can be reliably detected with high sensitivity and specificity using a locked, automated algorithm-based phonocardiogram analysis (also referred to as computer aided auscultation (CAA)).

Each patient is auscultated and diagnosed independently by a medical specialist. Additionally, for each patient, an echocardiogram is performed as the gold-standard for determining heart pathologies. The CAA results are compared to the findings of the medical professionals as well as to the echocardiogram findings.

Hypothesis: The specific (locked) CAA algorithms used in this study are able to automatically diagnose pathological heart murmurs in premature babies and newborns with at least the same accuracy as experienced medical specialists.

Condition or Disease Intervention/Treatment Phase
  • Device: Computer aided auscultation (CAA)

Detailed Description

The following registry procedures and quality factors have been implemented:
  • Quality assurance plan, including

  • data validation

  • proper registration procedures

  • regular site monitoring

  • regular auditing

  • Data checks to compare data entered into the registry against predefined rules for range or consistency with other data fields in the registry.

  • Source data verification to assess the accuracy, completeness, or representativeness of registry data by comparing the data to external data sources (medical records and paper case report forms).

  • Standard Operating Procedures to address registry operations and analysis activities, such as patient recruitment, data collection, data management, data analysis, reporting for adverse events, and change management.

  • Sample size assessment to specify the number of participants or participant years necessary to demonstrate an effect.

  • Statistical analysis plan describing the analytical principles and statistical techniques to be employed in order to address the primary and secondary objectives, as specified in the study protocol or plan.

  • Plan for missing data to address situations where variables are reported as missing, unavailable, "non-reported," uninterpretable, or considered missing because of data inconsistency or out-of-range results.

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
220 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Automated Algorithm Based Analysis of Phonocardiograms of Newborns
Actual Study Start Date :
Nov 1, 2013
Actual Primary Completion Date :
Jan 25, 2016
Actual Study Completion Date :
Jan 18, 2017

Outcome Measures

Primary Outcome Measures

  1. Number of correctly diagnosed heart murmurs through locked, independent algorithm based auscultation and traditional stethoscope based auscultation by medical experts [2 years (expected)]

    Each patient is screened and diagnosed regarding a potential heart murmur by a medical expert through standard stethoscope based auscultation. Heart sounds are recorded using an electronic stethoscope and analyzed and diagnosed independently (with no external input) by a locked algorithm. A final diagnoses for each patient is made by a medical expert by performing an echocardiogram, the gold standard method for heart murmur detection. The diagnoses of both the medical expert and the algorithm are finally compared to the echocardiogram based diagnosis (after completion of patient recruitment).

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Minute to 5 Days
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • any premature baby or newborn

  • parental approval for study participation

Exclusion Criteria:
  • none

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital Graz Styria Austria 8010

Sponsors and Collaborators

  • CSD Labs GmbH

Investigators

  • Principal Investigator: Gerhard Pichler, MD, Medical University of Graz

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
CSD Labs GmbH
ClinicalTrials.gov Identifier:
NCT02105480
Other Study ID Numbers:
  • GRZ02 (AAAPN)
First Posted:
Apr 7, 2014
Last Update Posted:
Jul 17, 2018
Last Verified:
Jul 1, 2018

Study Results

No Results Posted as of Jul 17, 2018